Induction of interferon-α by immune complexes or liposomes containing systemic lupus erythematosus autoantigen- and Sjögren's syndrome auto antigen - Associated RNA

Arthritis and Rheumatism

Volumn 54, Issue 6, 2006, Pages 1917-1927

  Lövgren, Tanja ^a,e   Eloranta, Maija Leena ^b   Kastner, Berthold ^c   Wahren Herlenius, Marie ^d   Alm, Gunnar V ^b   Rönnblom, Lars ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^c MAX PLANCK INSTITUTE FOR BIOPHYSICAL CHEMISTRY   (Germany)

^d KAROLINSKA INSTITUTE   (Sweden)

^e UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIGEN; AUTOANTIGEN; BAFILOMYCIN; BAFILOMYCIN A; CD14 ANTIGEN; CHLOROQUINE; DENDRITIC CELL ANTIGEN 2; FC RECEPTOR; FC RECEPTOR 2A; LIPOFECTIN; LIPOSOME; RIBONUCLEASE; RNA BINDING PROTEIN; SMALL NUCLEAR RNA; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

ANTIGEN ANTIBODY COMPLEX; ARTICLE; AUTOIMMUNE DISEASE; CELL CULTURE; CONTROLLED STUDY; DENDRITIC CELL; ENDOCYTOSIS; HUMAN; HUMAN CELL; INTERFERON PRODUCTION; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTIGEN-ANTIBODY COMPLEX; ANTIGENS, CD; AUTOANTIGENS; CELLS, CULTURED; FLOW CYTOMETRY; HUMANS; IMMUNOGLOBULIN G; INTERFERON-ALPHA; LUPUS ERYTHEMATOSUS, SYSTEMIC; MONOCYTES; PHOSPHATIDYLETHANOLAMINES; RECEPTORS, IGG; RNA, SMALL NUCLEAR; SJOGREN'S SYNDROME;

EID: 33745030751     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.21893     Document Type: Article

References (59)

1. Riboldi P, Gerosa M, Moroni G, Radice A, Allegri F, Sinico A, et al. Anti-DNA antibodies: a diagnostic and prognostic tool for systemic lupus erythematosus? [review]. Autoimmunity 2005;38:39-45.
2. Franceschini F, Cavazzana I. Anti-Ro/SSA and La/SSB antibodies [review]. Autoimmunity 2005;38:55-63.
3. Migliorini P, Baldini C, Rocchi V, Bombardieri S. Anti-Sm and anti-RNP antibodies [review]. Autoimmunity 2005;38:47-54.
4. Ronnblom L, Alm GV. A pivotal role for the natural interferon α-producing cells (plasmacytoid dendritic cells) in the pathogenesis of lupus [review]. J Exp Med 2001;194:F59-63.
5. Ronnblom L, Alm GV. The natural interferon-α producing cells in systemic lupus erythematosus [review]. Hum Immunol 2002;63: 1181-93.
6. Theofilopoulos AN, Baccala R, Beutler B, Kono DH. Type I interferons (α/β) in immunity and autoimmunity [review]. Annu Rev Immunol 2005;23:307-36.
7. Ytterberg SR, Schnitzer TJ. Serum interferon levels in patients with systemic lupus erythematosus. Arthritis Rheum 1982;25: 401-6.
8. Preble OT, Black RJ, Friedman RM, Klippel JH, Vilcek J. Systemic lupus erythematosus: presence in human serum of an unusual acid-labile leukocyte interferon. Science 1982;216:429-31.
9. Strannegard O, Hermodsson S, Westberg G. Interferon and natural killer cells in systemic lupus erythematosus. Clin Exp Immunol 1982;50:246-52.
10. Bengtsson AA, Sturfelt G, Truedsson L, Blomberg J, Alm G, Vallin H, et al. Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies. Lupus 2000;9:664-71.
11. Baechler EC, Batliwalla FM, Karypis G, Gaffney PM, Ortmann WA, Espe KJ, et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci USA 2003;100:2610-5.
12. Ioannou Y, Isenberg DA. Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy [review]. Arthritis Rheum 2000;43:1431-42.
13. Kalkner KM, Ronnblom L, Karlsson Parra AK, Bengtsson M, Olsson Y, Oberg K. Antibodies against double-stranded DNA and development of polymyositis during treatment with interferon. QJM 1998;91:393-9.
14. Raanani P, Ben-Bassat I. Immune-mediated complications during interferon therapy in hematological patients [review]. Acta Haematol 2002;107:133-44.
15. Ronnblom LE, Alm GV, Oberg KE. Possible induction of systemic lupus erythematosus by interferon-á treatment in a patient with a malignant carcinoid tumour. J Intern Med 1990;227:207-10.
16. Sigurdsson S, Nordmark G, Goring HH, Lindroos K, Wiman AC, Sturfelt G, et al. Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am J Hum Genet 2005;76:528-37.
17. Jorgensen TN, Gubbels MR, Kotzin BL. Links between type I interferons and the genetic basis of disease in mouse lupus [review]. Autoimmunity 2003;36:491-502.
18. Tough DF. Type I interferon as a link between innate and adaptive immunity through dendritic cell stimulation [review]. Leuk Lymphoma 2004;45:257-64.
19. Hueber W, Zeng D, Strober S, Utz PJ. Interferon-α-inducible proteins are novel autoantigens in murine lupus. Arthritis Rheum 2004;50:3239-49.
20. Vallin H, Perers A, Alm GV, Ronnblom L. Anti-double-stranded DNA antibodies and immunostimulatory plasmid DNA in combination mimic the endogenous IFN-α inducer in systemic lupus erythematosus. J Immunol 1999;163:6306-13.
21. Vallin H, Blomberg S, Alm GV, Cederblad B, Ronnblom L. Patients with systemic lupus erythematosus (SLE) have a circulating inducer of interferon-α (IFN-α) production acting on leucocytes resembling immature dendritic cells. Clin Exp Immunol 1999;115:196-202.
22. Bave U, Magnusson M, Eloranta ML, Perers A, Alm GV, Ronnblom L. FcγRIIa is expressed on natural IFN-α-producing cells (plasmacytoid dendritic cells) and is required for the IFN-α production induced by apoptotic cells combined with lupus IgG. J Immunol 2003;171:3296-302.
23. Means TK, Latz E, Hayashi F,.Murali MR, Golenbock DT, Luster AD. Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J Clin Invest 2005;115: 407-17.
24. Cederblad B, Blomberg S, Vallin H, Perers A, Alm GV, Ronnblom L. Patients with systemic lupus erythematosus have reduced numbers of circulating natural interferon-α producing cells. J Autoimmun 1998;11:465-70.
25. Blomberg S, Eloranta ML, Cederblad B, Nordlin K, Alm GV, Ronnblom L. Presence of cutaneous interferon-α producing cells in patients with systemic lupus erythematosus. Lupus 2001;10: 484-90.
26. Farkas L, Beiske K, Lund-Johansen F, Brandtzaeg P, Jahnsen FL. Plasmacytoid dendritic cells (natural interferon-α/β-producing cells) accumulate in cutaneous lupus erythematosus lesions. Am J Pathol 2001;159:237-43.
27. Lovgren T, Eloranta ML, Bave U, Alm GV, Ronnblom L. Induction of interferon-α production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG. Arthritis Rheum 2004;50:1861-72.
28. Bave U, Alm GV, Ronnblom L. The combination of apoptotic U937 cells and lupus IgG is a potent IFN-α inducer. J Immunol 2000;165:3519-26.
29. Bave U, Nordmark G, Lovgren T, Ronnelid J, Cajander S, Eloranta ML, et al. Activation of the type I Interferon system in primary Sjögren's syndrome: a possible etiopathogenic mechanism. Arthritis Rheum 2005;52:1185-95.
30. Hjelmervik TO, Petersen K, Jonassen I, Jonsson R, Bolstad AI. Gene expression profiling of minor salivary glands clearly distinguishes primary Sjögren's syndrome patients from healthy control subjects. Arthritis Rheum 2005;52:1534-44.
31. Yoneyama M, Kikuchi M, Matsumoto K, Imaizumi T, Miyagishi M, Taira K, et al. Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J Immunol 2005;175:2851-8.
32. Takeda K, Kaisho T, Akira S. Toll-like receptors [review]. Annu Rev Immunol 2003;21:335-76.
33. Bach M, Krol A, Luhrmann R. Structure-probing of U1 snRNPs gradually depleted of the U1-specific proteins A, C and 70k: evidence that A interacts differentially with developmentally regulated mouse U1 snRNA variants. Nucleic Acids Res 1990;18: 449-57.
34. Kastner B, Luhrmann R. Electron microscopy of U1 small nuclear ribonucleoprotein particles: shape of the particle and position of the 5′ RNA terminus. EMBO J 1989;8:277-86.
35. Krug A, Rothenfusser S, Hornung V, Jahrsdorfer B, Blackwell S, Ballas ZK, et al. Identification of CpG oligonucleotide sequences with high induction of IFN-α/β in plasmacytoid dendritic cells. Eur J Immunol 2001;31:2154-63.
36. Jurk M, Heil F, Vollmer J, Schetter C, Krieg AM, Wagner H, et al. Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848 [letter]. Nat Immunol 2002;3:499.
37. Lenert P, Stunz L, Yi AK, Krieg AM, Ashman RF. CpG stimulation of primary mouse B cells is blocked by inhibitory oligode-oxyribonucleotides at a site proximal to NF-κB activation. Antisense Nucleic Acid Drug Dev 2001;11:247-56.
38. Blomberg S, Eloranta ML, Magnusson M, Alm GV, Ronnblom L. Expression of the markers BDCA-2 and BDCA-4 and production of interferon-α by plasmacytoid dendritic cells in systemic lupus erythematosus. Arthritis Rheum 2003;48:2524-32.
39. Hacker H, Mischak H, Miethke T, Liptay S, Schmid R, Sparwasser T, et al. CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation. EMBO J 1998;17: 6230-40.
40. Rosen A, Casciola-Rosen L. Altered autoantigen structure in Sjögren's syndrome: implications for the pathogenesis of autoimmune tissue damage [review]. Crit Rev Oral Biol Med 2004;15: 156-64.
41. Almofti MR, Harashima H, Shinohara Y, Almofti A, Baba Y, Kiwada H. Cationic liposome-mediated gene delivery: biophysical study and mechanism of internalization. Arch Biochem Biophys 2003;410:246-53.
42. Miller CR, Bondurant B, McLean SD, McGovern KA, O'Brien DF. Liposome-cell interactions in vitro: effect of liposome surface charge on the binding and endocytosis of conventional and sterically stabilized liposomes. Biochemistry 1998;37:12875-83.
43. Barchet W, Cella M, Colonna M. Plasmacytoid dendritic cells: virus experts of innate immunity [review]. Semin Immunol 2005; 17:253-61.
44. Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, Akira S, et al. Species-specific recognition of single-stranded RNA via Toll-like receptor 7 and 8. Science 2004;303:1526-9.
45. Magnusson M, Magnusson S, Vallin H, Ronnblom L, Alm GV. Importance of CpG dinucleotides in activation of natural IFN-α-producing cells by a lupus-related oligodeoxynucleotide. Scand J Immunol 2001;54:543-50.
46. Hornung V, Schlender J, Guenthner-Biller M, Rothenfusser S, Endres S, Conzelmann KK, et al. Replication-dependent potent IFN-α induction in human plasmacytoid dendritic cells by a single-stranded RNA virus. J Immunol 2004;173:5935-43.
47. Siren J, Pirhonen J, Julkunen I, Matikainen S. IFN-α regulates TLR-dependent gene expression of IFN-α, IFN-β, IL-28, and IL-29. J Immunol 2005;174:1932-7.
48. Hoffman RW, Gazitt T, Foecking MF, Ortmann RA, Misfeldt M, Jorgenson R, et al. U1 RNA induces innate immunity signaling. Arthritis Rheum 2004;50:2891-6.
49. Will CL, Luhrmann R. Spliceosomal UsnRNP biogenesis, structure and function. Curr Opin Cell Biol 2001;13:290-301.
50. Kariko K, Buckstein M, Ni H, Weissman D. Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity 2005;23: 165-75.
51. Jurk M, Kritzler A, Schulte B, Uhlmann E, Schetter C, Krieg A, et al. Selective inhibition of Toll-like receptor-mediated signaling by inhibitory oligodeoxynucleotides [abstract]. Clin Invest Med 2004; 27:2333.
52. Hornung V, Guenthner-Biller M, Bourquin C, Ablasser A, Schlee M, Uematsu S, et al. Sequence-specific potent induction of IFN-α by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat Med 2005;11:263-70.
53. Barrat FJ, Meeker T, Gregorio J, Chan JH, Uematsu S, Akira S, et al. Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus. J Exp Med 2005;202:1131-9.
54. Gorden KB, Gorski KS, Gibson SJ, Kedl RM, Kieper WC, Qiu X, et al. Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8. J Immunol 2005;174:1259-68.
55. Takai T. Fc receptors and their role in immune regulation and autoimmunity [review]. J Clin Immunol 2005;25:1-18.
56. Kirou KA, Lee C, George S, Louca K, Peterson MG, Crow MK. Activation of the interferon-α pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease. Arthritis Rheum 2005;52:1491-503.
57. Ronnblom L, Eloranta ML, Alm G. The type I interferon system in systemic lupus erythematosus [review]. Arthritis Rheum 2006; 54:408-20.
58. Vollmer J, Tluk S, Schmitz C, Hamm S, Jurk M, Forsbach A, et al. Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8. J Exp Med. 2005;202:1575-85.
59. Lau CM, Broughton C, Tabor AS, Akira S, Flavell RA, Mamula MJ, et al. RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement. J Exp Med 2005;202:1171-7.